REVIEW OF BRCA1 AND BRCA2 MUTATION SCREENING STRATEGIES FOR REDUCING CANCER BURDEN IN HIGH-RISK FAMILIES
Axis Community Research Journal (ACRJ) · 30.11.2024 · 2 (1) · 36-46
DOI: 10.67129/ys05q690 ↗Kurz gefasst
Fachartikel in der Zeitschrift Axis Community Research Journal (ACRJ), online erschienen am 30.11.2024. Verfasst von Murtaza Khodadadi und 1 weiteren Autor:innen. Die Arbeit nennt 24 Literaturangaben.
Abstract (Originalsprache)
Background
Pathogenic variants in the BRCA1 and BRCA2 genes significantly elevate the lifetime risk of breast, ovarian, and other cancers, creating a substantial burden for high-risk families. Identifying carriers is paramount for implementing evidence-based risk-reduction strategies, yet the optimal approach to population screening remains a subject of refinement. This narrative review synthesizes the current landscape of BRCA screening methodologies and their impact on cancer outcomes.
Objective
This review aims to summarize and critically evaluate existing literature on various BRCA1 and BRCA2 mutation screening strategies, with a focus on their effectiveness in identifying carriers in high-risk families and their subsequent role in reducing familial cancer incidence. Main Discussion Points: The discussion is structured around key thematic developments. It begins with the established model of family history-based screening and clinical prediction tools, acknowledging their utility and significant limitations. The review then explores the shift towards broader paradigms, including the mainstreaming of genetic testing into oncology care and the emerging evidence for population-based screening in specific founder populations. A critical analysis is presented on how a positive genetic test result translates into clinical action, encompassing risk-reducing surgeries and targeted therapies, and ultimately impacts cancer burden. The synthesis also addresses unresolved challenges, such as variants of uncertain significance and disparities in access to genetic services.
Conclusion
The evidence supports a move beyond reliance on family history alone towards more inclusive and proactive screening models to identify a greater proportion of BRCA carriers. While the clinical utility of genetic testing is well-established for guiding risk management and therapy, future efforts must focus on improving the implementation, accessibility, and equity of these strategies to maximize their public health benefit in diverse populations.
Zitieren
APA
Khodadadi, M., & Mansoor, A. (2024). REVIEW OF BRCA1 AND BRCA2 MUTATION SCREENING STRATEGIES FOR REDUCING CANCER BURDEN IN HIGH-RISK FAMILIES. Axis Community Research Journal (ACRJ), 2(1), 36-46. https://doi.org/10.67129/ys05q690
Vancouver
Khodadadi M, Mansoor A. REVIEW OF BRCA1 AND BRCA2 MUTATION SCREENING STRATEGIES FOR REDUCING CANCER BURDEN IN HIGH-RISK FAMILIES. Axis Community Research Journal (ACRJ). 2024;2(1):36-46. doi:10.67129/ys05q690
BibTeX
@article{Khodadadi2024,
author = {Khodadadi, Murtaza and Mansoor, Alina},
title = {REVIEW OF BRCA1 AND BRCA2 MUTATION SCREENING STRATEGIES FOR REDUCING CANCER BURDEN IN HIGH-RISK FAMILIES},
journal = {Axis Community Research Journal (ACRJ)},
year = {2024},
volume = {2},
number = {1},
pages = {36--46},
doi = {10.67129/ys05q690}
}
EUVIMED